GRWR Correlates with the Metabolism of Tacrolimus after Pediatric Living Donor Liver Transplantation According to Donor CYP3A5 Polymorphism

Table 5

Comparison of TAC dose requirement among the 4 groups.

Posttransplant time	TAC dose requirement (mg/kg/d)
	SS/NEX group ()	SS/EX group ()	LS/NEX group ()	LS/EX group ()
3 days	0.11 (0.09-0.13)	0.12 (0.11-0.16)	0.14 (0.13-0.17)	0.14 (0.12-0.15)
7 days	0.10 (0.06-0.13)	0.12 (0.08-0.16)	0.13 (0.08-0.17)	0.18 (0.13-0.20)
14 days	0.13 (0.08-0.17)	0.21 (0.12-0.26)	0.17 (0.14-0.24)	0.25 (0.18-0.28)
1 month	0.18 (0.10-0.23)	0.22 (0.17-0.32)	0.23 (0.19-0.27)	0.25 (0.21-0.32)
3 months	0.14 (0.11-0.17)	0.23 (0.18-0.28)	0.18 (0.13-0.22)	0.22 (0.20-0.24)
6 months	0.10 (0.07-0.12)	0.18 (0.13-0.23)	0.11 (0.07-0.14)	0.16 (0.10-0.18)
12 months	0.07 (0.04-0.09)	0.11 (0.08-0.16)	0.05 (0.04-0.09)	0.08 (0.04-0.12)

Note: Data are expressed as median (lower quartile-upper qurtile). indicates compared with the SS/NEX group; indicates compared with the SS/NEX group.